Teva Stock: Teva Guides To Its First Year Of Growth Since 2017, But There's A Caveat | Investor's Business Daily
Teva looks to amp up research collaborations, CEO says
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceuticals Office Photos | Glassdoor
Amicus' Acquiescence To Teva's Drug Supply Request Reflects Power Of CREATES Act :: Pink Sheet
teva News and latest stories | The Jerusalem Post
TEVA.N) | Stock Price & Latest News | Reuters
Teva Wins Ruling Tossing $235 Million Glaxo Drug Verdict - Bloomberg
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Why Teva Pharmaceuticals Stock Has Two A-Products In The Bag (NYSE:TEVA) | Seeking Alpha
Teva Eyes 25 Percent of the $750 Million EpiPen Market by Year's End | BioSpace
Buy Teva Pharmaceuticals amid positive news, Bernstein says
Lured by $40 million tax break, Teva moving U.S. headquarters from Pa. to North Jersey - WHYY
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva sells Overland Park business segment - Kansas City Business Journal
Teva reaches $4.25B deal to settle opioid lawsuits | The Hill
Teva Pharmaceutical Layoffs - TheLayoff.com
Teva bought the pharm, and now it may have bought the farm | The Times of Israel
Teva Pharm Expects to Start Paying U.S. Opioid Settlement in 2023
Teva to pay New York $500M for role in opioid crisis - POLITICO
J&J, Teva offer a whopping $48B combined to wrap opioid suits, but not all plaintiffs are on board | Fierce Pharma
teva News and latest stories | The Jerusalem Post
Pharmaceutical Company Reaches Settlement With Oklahoma In Opioid Case : NPR
Teva quits brand lobby PhRMA, in line to lead generic lobby AAM - STAT
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
